These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15991760)

  • 1. Becoming 'indispensable': developing innovative community pharmacy practices.
    Willink DP; Isetts BJ
    J Am Pharm Assoc (2003); 2005; 45(3):376-86; quiz 387-9. PubMed ID: 15991760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stepwise approach to developing point-of-care testing services in the community/ambulatory pharmacy setting.
    Rodis JL; Thomas RA
    J Am Pharm Assoc (2003); 2006; 46(5):594-604. PubMed ID: 17036646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of pharmaceutical care among pharmacists offering compounding services.
    Yancey V; Yakimo R; Perry A; McPherson TB
    J Am Pharm Assoc (2003); 2008; 48(4):508-14. PubMed ID: 18653427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing health literacy practices in a community pharmacy environment: experiences using the AHRQ Pharmacy Health Literacy Assessment Tool.
    O'Neal KS; Crosby KM; Miller MJ; Murray KA; Condren ME
    Res Social Adm Pharm; 2013; 9(5):564-96. PubMed ID: 23267822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance-based pharmacy payment models: key components and critical implementation considerations for successful uptake and integration.
    Richard C; Urick BY; Pathak S; Jackson J; Livet M
    J Manag Care Spec Pharm; 2021 Nov; 27(11):1568-1578. PubMed ID: 34714107
    [No Abstract]   [Full Text] [Related]  

  • 7. Community pharmacists' experience and perceptions of the New Medicines Service (NMS).
    Lucas B; Blenkinsopp A
    Int J Pharm Pract; 2015 Dec; 23(6):399-406. PubMed ID: 25712253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist involvement with immunizations: a decade of professional advancement.
    Hogue MD; Grabenstein JD; Foster SL; Rothholz MC
    J Am Pharm Assoc (2003); 2006; 46(2):168-79; quiz 179-82. PubMed ID: 16602227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical networks influencing policy and practice: the establishment of advanced practice pharmacist roles for specialist palliative care services in South Australia.
    Swetenham K; Rowett D; Stephenson D
    Aust Health Rev; 2014 May; 38(2):238-41. PubMed ID: 24670916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing patient care through innovative practice: the Clinical Partners Program.
    Mehta BH; Rodis JL; Nahata MC; Bennett MS
    Am J Health Syst Pharm; 2005 Dec; 62(23):2501-7. PubMed ID: 16303906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
    Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
    J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare Annual Wellness Visits: A Scoping Review of Current Practice Models and Opportunities for Pharmacists.
    Hohmann LA; Hastings TJ; Qian J; Curran GM; Westrick SC
    J Pharm Pract; 2020 Oct; 33(5):666-681. PubMed ID: 31232218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to facilitate the implementation of collaborative practice agreements in chain community pharmacies.
    Bacci JL; Coley KC; McGrath K; Abraham O; Adams AJ; McGivney MS
    J Am Pharm Assoc (2003); 2016; 56(3):257-265.e2. PubMed ID: 27053276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exploratory study of the views of community pharmacy staff on the management of patients with undiagnosed skin problems.
    Tucker R; Stewart D
    Int J Pharm Pract; 2015 Dec; 23(6):390-8. PubMed ID: 25689029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program.
    Carter BL; Chrischilles EA; Scholz D; Hayase N; Bell N
    J Am Pharm Assoc (Wash); 2003; 43(1):24-33. PubMed ID: 12585748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming community-based pharmacy practice through financially sustainable centers for health and personal care.
    Schommer JC; Olson AW; Isetts BJ
    J Am Pharm Assoc (2003); 2019; 59(3):306-309. PubMed ID: 30573373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rural health systems' perceptions of referral to community pharmacists during transitions of care.
    Paul S; DiDonato KL; Liu Y; Hartwig DM; May J; Schramm AM
    J Am Pharm Assoc (2003); 2016; 56(5):562-567.e2. PubMed ID: 27475835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.